HIGH CANNABIDIOL CANNABIS STRAINS
The invention described herein relates to a cannabis cultivar that produces high concentrations of cannabidiol. The invention further relates to preparations and products derived from the cannabis cultivar. Also provided are methods of treating conditions that are treatable by cannabidiol. by administering a preparation or product derived from the cannabis cultivar.
1 . A cannabis cultivar that produces an assayable combined cannabidiolic acid and cannabidiol concentration of at least about 20% by weight.
2 . The cannabis cultivar of claim 1 that produces an assayable combined Δ9-tetrahydrocannabinol and tetrahydrocannabinolic acid concentration of less than about 0.1% by weight.
3 . The cannabis cultivar of claim 1 , wherein the estimated active cannabidiol concentration is at least about 20% by weight.
4 . The cannabis cultivar of claim 1 , wherein the active Δ9-tetrahydrocannabinol concentration is less than about 0.1% by weight.
5 . The cannabis cultivar of claim 1 , wherein the cannabinoid concentration is determined based on a moisture content of between about 5% and about 10%.
6 . The cannabis cultivar of claim 5 , wherein the cannabinoid concentration is determined based on a moisture content of between about 8% and about 10%.
7 . A seed of the cannabis cultivar of claim 1 .
8 . A clone of the cannabis cultivar of claim 1 .
9 . A cannabis product that is a dehydrated portion of the cannabis cultivar of claim 1 .
10 . The cannabis product of claim 9 , wherein the dehydrated portion is one or more of an inflorescence, a flower, a leaf, or a stem.
11 . A preparation of the cannabis cultivar of claim 1 , wherein the preparation is a flower, an extract, an oil, an edible, a kief, an infusion, a tincture, or a hashish.
12 . The preparation of claim 11 , wherein the preparation is an oil.
13 . The preparation of claim 12 , comprising less than about 1% by weight of a solvent used for extraction.
14 . The preparation of claim 1 in a container that is impervious to visible light.
15 . A method of treating a cannabidiol-treatable condition and/or symptom thereof in a patient in need thereof, the method comprising administering to the patient an effective amount of a composition comprising the cannabis cultivar of claim 1 , wherein the condition and/or symptom is treated.
16 . The method of claim 15 , wherein the condition is selected from the group consisting of: cancer, nausea, chronic pain, spasms, seizures, epilepsy, anxiety, psoriasis, Crohn's disease, rheumatoid arthritis, diabetes, schizophrenia, post-traumatic stress disorder, alcoholism, strokes, Multiple Sclerosis, and cardiovascular disease.
17 . A unit dose of the cannabis cultivar of claim 1 .
18 . The unit dose of claim 17 comprising up to about 300 mg of cannabidiol and/or cannabidiolic acid.
19 . The unit dose of claim 17 comprising less than about 12 mg Δ9-tetrahydrocannabinol and/or tetrahydrocannabinolic acid.
20 . A composition comprising atomized cannabidiol and/or cannabidiolic acid, wherein the ratio of atomized cannabidiol and/or cannabidiolic acid to atomized Δ9-tetrahydrocannabinol and/or tetrahydrocannabinolic acid is between about 300:1 and about 25:1.
21 . The composition of claim 20 , wherein the atomized cannabidiol and/or cannabidiolic acid is provided by an electronic cigarette, a nebulizer, or a vaporizer.